Company Data
Resverlogix Corp.
Ticker
RVX:CA
Current Price
$0.05
Market Cap
$14.0M
Price Target
Refer to Report
Volume
95.0K
52wk Range
$0.04 - $0.095
Overview
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.